ISTANBUL escrs

Cystoid macular oedema after cataract surgery

Session Details

Session Title: Cataract 2
Session Date/Time: Saturday 21/02/2015 | 08:30-11:00
Paper Time: 08:57
Venue: Hall 1
First Author: : R.Johnston UK
Co Author(s): :    C. Chu              

Abstract Details

Purpose:

To report the incidence of post-cataract surgery cystoid macular oedema (CMO) in all eyes, eyes of patients with diabetes without retinopathy and eyes with retinopathy.

Setting:

A single centre electronic medical record database study, at a centre that does not use non-steroidal anti-inflammatory prophylaxis. Gloucestershire Hospitals NHS Foundation Trust, Cheltenham General Hospital, Sandford Road, Cheltenham, GL53 7AN.

Methods:

The Royal College of Ophthalmologists’ Cataract National Dataset was prospectively collected within an electronic medical record (EMR) system (Medisoft Ophthalmology, Leeds, UK) after consecutive cataract operations. Data collection included: pupil size, additional procedures performed and compulsory reporting of the presence or absence of operative and post-operative complications. Automated audit reports within the EMR were used to report the incidence of cystoid macular oedema in different cohorts of patients.

Results:

The overall incidence of post-operative CMO was 2.2% after 12,474 cataract operations, increasing to 5.1% in eyes of patients with diabetes and 11.2% in eyes with diabetic retinopathy pre-operatively.

Conclusions:

Diabetes and the presence of diabetic retinopathy substantially increase the incidence of post-operative cystoid macular oedema. Highlighting the need for prophylactic treatment

Financial Disclosure:

One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a competing company

Back to previous